Merck and Huma Therapeutics launch innovative app to support bladder cancer patients
Posted:
London headquartered Huma Therapeutics, together with Germany's Merck KGaA, has announced the launch of their innovative bladder cancer treatment companion app in the United Kingdom.
Wearable medical devices are changing healthcare delivery by shifting care beyond traditional settings and bringing it closer to patients’ daily lives. By offering continuous monitoring, promoting patient engagement and supporting remote interventions, these technologies are becoming an essential part of…
Attendees
Sponsors and Exhibitors
Agenda 2025
Contact us